|
91
|
|
|
Fatty acid binding protein 3 |
FABP11, H-FABP, M-FABP, MDGI, O-FABP |
|
|
92
|
|
|
Fatty acid binding protein 5 |
E-FABP, EFABP, KFABP, PA-FABP, PAFABP |
|
|
93
|
|
|
Fatty acid binding protein 7 |
B-FABP, BLBP, FABPB, MRG |
|
|
94
|
|
|
FA complementation group A |
FA, FA-H, FA1, FAA, FACA, FAH, FANCH |
Basal cell carcinoma, Biliary tract cancer, Breast cancer, Cancer, Adenoid cystic carcinoma, Cervical cancer, Colorectal cancer, Melanoma, Endometrial cancer, Esophageal cancer, Estrogen-receptor negative breast cancer, Fanconi anemia, Gastric cancer, Hepatocellular carcinoma, Hyperinsulinism, Keratinocyte carcinoma, Lung cancer, Renal pelvis cancer, Neurodevelopmental disorders, Non-hodgkins lymphoma, Non-melanoma skin carcinoma, Open angle glaucoma, Ovarian cancer, Premature ovarian failure, Ovarian serous carcinoma, Pancreatic cancer, Pituitary stalk interruption syndrome, Prostate cancer, Salivary gland neoplasms, Schizophrenia, Squamous cell carcinoma, Stroke, Urinary tract infection, VitiligoView all (19 more) |
|
95
|
|
|
FA complementation group C |
FA3, FAC, FACC |
Atrial fibrillation, Color vision deficiency, Colorectal cancer, Congenital cardiovascular anomaly, Esophageal squamous cell carcinoma, Fanconi anemia, Hyperinsulinism, Dermatomyositis, Pancreatic cancer, Neurotic disorder, Ovarian cancer, Premature ovarian failure, Pancytopenia, Peripheral vascular disease, Prostate cancer, Diabetes mellitus, type 2View all (1 more) |
|
96
|
|
|
FA complementation group D2 |
FA-D2, FA4, FACD, FAD, FAD2, FANCD |
|
|
97
|
|
|
FA complementation group E |
FACE, FAE |
|
|
98
|
|
|
Fumarylacetoacetate hydrolase |
- |
|
|
99
|
|
|
FA complementation group B |
FA2, FAAP90, FAAP95, FAB, FACB |
|
|
100
|
|
|
FA complementation group F |
FAF |
|
